Cargando…

Sex differences in risk of Alzheimer's disease in adults with Down syndrome

INTRODUCTION: Adults with Down syndrome (DS) older than 40 have Alzheimer's disease (AD) neuropathology and high risk for dementia, but little is known about the relationship of sex to AD risk in this population. METHODS: Using nonparametric methods and Cox proportional hazards models we analyz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Florence, Mhatre, Pooja G., Yang, Yuchen, Wang, Mei‐Cheng, Schupf, Nicole, Rosas, H. Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507514/ https://www.ncbi.nlm.nih.gov/pubmed/32995462 http://dx.doi.org/10.1002/dad2.12084

Ejemplares similares

The Association between Sex and Risk of Alzheimer’s Disease in Adults with Down Syndrome
por: Mhatre, Pooja Girish, et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Altered connectivity of the default mode network in cognitively stable adults with Down syndrome: “Accelerated aging” or a prelude to Alzheimer's disease?
por: Rosas, H. Diana, et al.
Publicado: (2021)

Language skills as a predictor of cognitive decline in adults with Down syndrome
por: Pulsifer, Margaret B., et al.
Publicado: (2020)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models
por: Hom, Christy L., et al.
Publicado: (2021)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Association between Hypothyroidism Onset and Alzheimer Disease Onset in Adults with Down Syndrome
por: Lai, Florence, et al.
Publicado: (2021)

Promising outcome measures of early Alzheimer's dementia in adults with Down syndrome
por: Krinsky‐McHale, Sharon J, et al.
Publicado: (2020)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

Association between Inflammatory Conditions and Alzheimer’s Disease Age of Onset in Down Syndrome
por: Lai, Florence, et al.
Publicado: (2021)

Correction: Hom et al. Cognitive Function during the Prodromal Stage of Alzheimer’s Disease in Down Syndrome: Comparing Models. Brain Sci. 2021, 11, 1220
por: Hom, Christy L., et al.
Publicado: (2022)

Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: O'Bryant, Sid E., et al.
Publicado: (2020)

Individualized estimated years from onset of Alzheimer's disease– related decline for adults with Down syndrome
por: Silverman, Wayne, et al.
Publicado: (2023)

Pathways linking pulse pressure to dementia in adults with Down syndrome
por: Rizvi, Batool, et al.
Publicado: (2023)

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: Petersen, Melissa, et al.
Publicado: (2020)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome
por: Andrews, Elizabeth J., et al.
Publicado: (2022)

Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome
por: Lee, Joseph H., et al.
Publicado: (2012)

Down syndrome: Distribution of brain amyloid in mild cognitive impairment
por: Keator, David B., et al.
Publicado: (2020)

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome
por: Hartley, Sigan L., et al.
Publicado: (2023)

Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome
por: Iulita, M Florencia, et al.
Publicado: (2023)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

Joint‐label fusion brain atlases for dementia research in Down syndrome
por: Queder, Nazek, et al.
Publicado: (2022)

Cell models for Down syndrome-Alzheimer’s disease research
por: Wu, Yixing, et al.
Publicado: (2022)

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2021)

Neural correlates of episodic memory in adults with Down syndrome and Alzheimer’s disease
por: Benejam, Bessy, et al.
Publicado: (2022)

Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
por: Benejam, Bessy, et al.
Publicado: (2020)

Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
por: Wilcock, Donna M, et al.
Publicado: (2013)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Quantitative Electroencephalography as a Diagnostic Tool for Alzheimer's Dementia in Adults with Down Syndrome
por: Salem, Lise Cronberg, et al.
Publicado: (2015)

An improved method for detecting telomere size differences in T-lymphocyte interphases from older people with Down syndrome with and without mild cognitive impairment
por: Jenkins, E. C., et al.
Publicado: (2017)

Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome
por: Lleó, Alberto, et al.
Publicado: (2021)

Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease
por: Martinez, Jose L., et al.
Publicado: (2021)

β-Secretases, Alzheimer's Disease, and Down Syndrome
por: Webb, Robin L., et al.
Publicado: (2012)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
por: Montoliu-Gaya, Laia, et al.
Publicado: (2021)

Structural Connectivity in Down Syndrome and Alzheimer’s Disease
por: Saini, Fedal, et al.
Publicado: (2022)

Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer’s Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study
por: Hendrix, James A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_86129j66a3qcnejc5suddi977h